KING FAISAL SPECIALIST HOSPITAL & RESEARCH CENTER

🇸🇦Saudi Arabia
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Study to Assess Incidence of ONJ in Pts With Bone Mets Starting Zoledronic Acid Treatment

Completed
Conditions
Cancer
First Posted Date
2011-12-08
Last Posted Date
2019-03-01
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
100
Registration Number
NCT01488851
Locations
🇸🇦

King Faisal Specialist Hospital& Research Center, Riyadh, Saudi Arabia

A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors

Phase 2
Completed
Conditions
Malignant Salivary Gland Tumors
First Posted Date
2011-12-08
Last Posted Date
2016-02-25
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
120
Registration Number
NCT01488838
Locations
🇸🇦

King Faisal Specialist Hospital& Research Center, Riyadh, Saudi Arabia

Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma

Phase 3
Completed
Conditions
Glioblastoma
Interventions
Drug: TMZ
First Posted Date
2011-06-02
Last Posted Date
2016-02-25
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
1153
Registration Number
NCT01364064

Generic Formulations of Commonly-used Oral Drugs in Saudi Arabia:Interchangeability & Post-marketing Quality

First Posted Date
2011-04-28
Last Posted Date
2015-09-01
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
500
Registration Number
NCT01344070
Locations
🇸🇦

King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia

Study of the Clinical Efficacy of Autologous SCT in Patients With Critical Limb Ischemia

First Posted Date
2011-03-09
Last Posted Date
2011-12-13
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
26
Registration Number
NCT01311011
Locations
🇸🇦

Kfsh & Rc, Riyadh, Saudi Arabia

A Trial of Pre-Operative Chemoradiotherapy Using Capecitabine, Radiation & Cetuximab, in Rectal Cancer

First Posted Date
2011-03-09
Last Posted Date
2019-03-01
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
15
Registration Number
NCT01310985
Locations
🇸🇦

Kfsh & Rc, Riyadh, Saudi Arabia

Adjuvant Colon Cancer w/ ELOXatin®/5 FU Based Regimen: ACCELOX

Completed
Conditions
Colon Cancer
First Posted Date
2011-03-09
Last Posted Date
2018-08-10
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
6
Registration Number
NCT01310972
Locations
🇸🇦

Kfsh & Rc, Riyadh, Saudi Arabia

Establishment of Acute Lymphocytic Leukemia Data Base in the Department of Oncology

First Posted Date
2011-03-09
Last Posted Date
2011-12-13
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
203
Registration Number
NCT01310946
Locations
🇸🇦

Kfsh & Rc, Riyadh, Saudi Arabia

A Trial of Capecitabine (Xeloda), Oxaliplatin and Irinotecan in Combination With Bevacizumab in 1st Line Treatment of Metastatic Colorectal Cancer

First Posted Date
2011-03-09
Last Posted Date
2011-12-13
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
46
Registration Number
NCT01311050
Locations
🇸🇦

Kfsh & Rc, Riyadh, Saudi Arabia

Establishing a Data Base for Aplastic Anemia and Other Marrow Failure Syndrome

First Posted Date
2011-03-09
Last Posted Date
2011-12-13
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
88
Registration Number
NCT01310959
Locations
🇸🇦

Kfsh & Rc, Riyadh, Saudi Arabia

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy